Endocannabinoid-Deficiency-Syndrome-head photo.jpg

Clinical EndoCannabinoid Deficiency (CECD)

Clinical EndoCannabinoid Deficiency (CECD) is the theory that in  certain conditions, whether congenital or acquired,  endocannabinoid tone becomes deficient and productive of  pathophysiological syndromes. Its base hypothesis is that all humans have an underlying  endocannabinoid tone that is a reflection of levels of the  endocannabinoids, their production, metabolism, and the relative abundance and state of cannabinoid receptors.  Whole plant hemp flowers and CBD rich hemp extract are  abundant with naturally occurring amino acids, fatty acids and flavonoids that play a key role in increasing ECS efficiency  supporting homeostasis, as well as its disease abatement  potential.